Pharmaceutical drug pricing has become a critical global issue, with significant implications for healthcare access, affordability, and equity.
Despite its importance, AI applications in pharmaceutical drug pricing are still at a very early stage.
I will talk about generative and conversational AI as well as ML applications for Market Access & Pricing, a key activity to ensure a successful drug launch. I will highlight where those applications are already applied to make better and more informed decisions and where I see challenges and areas of improvement.
